1. Home
  2. PT vs AYTU Comparison

PT vs AYTU Comparison

Compare PT & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • AYTU
  • Stock Information
  • Founded
  • PT 2012
  • AYTU N/A
  • Country
  • PT China
  • AYTU United States
  • Employees
  • PT N/A
  • AYTU N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • PT Technology
  • AYTU Health Care
  • Exchange
  • PT Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • PT 14.8M
  • AYTU 15.0M
  • IPO Year
  • PT 2018
  • AYTU N/A
  • Fundamental
  • Price
  • PT $0.98
  • AYTU $2.24
  • Analyst Decision
  • PT
  • AYTU
  • Analyst Count
  • PT 0
  • AYTU 0
  • Target Price
  • PT N/A
  • AYTU N/A
  • AVG Volume (30 Days)
  • PT 39.9K
  • AYTU 32.2K
  • Earning Date
  • PT 04-30-2024
  • AYTU 11-12-2024
  • Dividend Yield
  • PT N/A
  • AYTU N/A
  • EPS Growth
  • PT N/A
  • AYTU N/A
  • EPS
  • PT N/A
  • AYTU N/A
  • Revenue
  • PT $7,434,458.00
  • AYTU $81,002,000.00
  • Revenue This Year
  • PT N/A
  • AYTU N/A
  • Revenue Next Year
  • PT N/A
  • AYTU N/A
  • P/E Ratio
  • PT N/A
  • AYTU N/A
  • Revenue Growth
  • PT N/A
  • AYTU N/A
  • 52 Week Low
  • PT $0.71
  • AYTU $2.11
  • 52 Week High
  • PT $1.38
  • AYTU $3.50
  • Technical
  • Relative Strength Index (RSI)
  • PT 48.96
  • AYTU 40.89
  • Support Level
  • PT $0.88
  • AYTU $2.11
  • Resistance Level
  • PT $1.01
  • AYTU $2.44
  • Average True Range (ATR)
  • PT 0.11
  • AYTU 0.14
  • MACD
  • PT -0.01
  • AYTU -0.02
  • Stochastic Oscillator
  • PT 61.11
  • AYTU 17.57

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

Share on Social Networks: